"Newborn screening for cystic fibrosis has been universal in the U.S. since 2010; however, there is significant variation ...

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to ...

The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...

Forty-thousand -- that's the number of children and adults in America with cystic fibrosis, or "C-F."It's a genetic disorder ...

The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in ...

Cystic fibrosis is a life-threatening genetic disease that clogs the lungs with thick, sticky mucus, leading to chronic infections and severe organ damage. Despite breakthrough medications that have ...

The introduction of highly effective modulator (elexacaftor/tezacaftor/ivacaftor) therapy improved the disease trajectory of cystic fibrosis (CF). However, its ...

Cystic fibrosis (CF) is a genetic condition that affects the lungs, pancreas and other organs, caused by variations on the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

A study across 11 U.S. CF centers analyzed 307 pregnancies from 2010 to 2021, assessing the impact of CFTR modulators on pregnancy outcomes in individuals with cystic fibrosis.

The interplay between muscle atrophy and fibrosis is a central feature of sarcopenia ... Small interfering RNA (siRNA) molecules were designed to specifically target the mRNA of the gene, IGFBP5, to ...